| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| xaliproden | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank , DGIDB | Amyotrophic Lateral Sclerosis[MeSHID:D000690] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lateral Sclerosis[MeSHID:D016472] Dental Plaque[MeSHID:D003773] Juvenile arthritis[MeSHID:D001171] Psoriasis[MeSHID:D011565] Senile Plaques[MeSHID:D058225] Esthesia[MeSHID:D012677] Peripheral Neuropathy[MeSHID:D010523] |
1.21 | investigational | unknown |
| xaliproden | 5-ht 1a receptor | NA | Successful target | TTD , DGIDB | Amyotrophic Lateral Sclerosis[MeSHID:D000690] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lateral Sclerosis[MeSHID:D016472] Dental Plaque[MeSHID:D003773] Juvenile arthritis[MeSHID:D001171] Psoriasis[MeSHID:D011565] Senile Plaques[MeSHID:D058225] Esthesia[MeSHID:D012677] Peripheral Neuropathy[MeSHID:D010523] |
1.21 | phase 3 | unknown |
| click here to return to the previous page | ||||||||